首页 | 本学科首页   官方微博 | 高级检索  
     


A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer
Authors:Margaret E. Gatti-Mays  Jason M. Redman  Renee N. Donahue  Claudia Palena  Ravi A. Madan  Fatima Karzai  Marijo Bilusic  Houssein Abdul Sater  Jennifer L. Marté  Lisa M. Cordes  Sheri McMahon  Seth M. Steinberg  Alanvin Orpia  Andrea Burmeister  Jeffrey Schlom  James L. Gulley  Julius Strauss
Affiliation:1. Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA;2. Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA;3. Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA;4. Leidos Biomedical Research, Inc., Frederick, Maryland, USA
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号